A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17 alpha-hydroxylase/17,20-lyase deficiency

J Endocrinol Invest. 2009 Apr;32(4):322-4. doi: 10.1007/BF03345720.

Abstract

The deficiency of 17 alpha-hydroxylase/17,20-lyase causes a rare autosomal recessive disorder presenting with congenital adrenal insufficiency (CAH) and sexual infantilism. Both 17 alpha-hydroxylase and 17,20-lyase reactions are catalyzed by a single polypeptide, cytochrome P450c17 (CYP17), which is encoded by the CYP17A1 gene. We describe the clinical, hormonal, and molecular findings of a 33-yr-old patient presenting with primary amenorrhea, late onset hypertension, and hypokalemic myopathy. The molecular analysis of CYP17A1 revealed a novel homozygous missense mutation resulting in the substitution of arginine to lysine at the amino acid position 21 (p.R21L).

Publication types

  • Case Reports

MeSH terms

  • Adrenal Hyperplasia, Congenital / enzymology
  • Adrenal Hyperplasia, Congenital / genetics*
  • Adult
  • Amenorrhea / genetics*
  • Amino Acid Substitution
  • DNA Mutational Analysis
  • DNA Primers / chemistry
  • DNA Primers / genetics
  • Female
  • Homozygote
  • Humans
  • Hypertension / genetics*
  • Hypokalemia / genetics*
  • Muscular Diseases
  • Mutation, Missense / genetics*
  • Steroid 17-alpha-Hydroxylase / genetics*
  • Steroid 17-alpha-Hydroxylase / metabolism

Substances

  • DNA Primers
  • CYP17A1 protein, human
  • Steroid 17-alpha-Hydroxylase